Impact of the spheroid model complexity on drug response

作者: Oliver Ingo Hoffmann , Christian Ilmberger , Stefanie Magosch , Mareile Joka , Karl-Walter Jauch

DOI: 10.1016/J.JBIOTEC.2015.02.029

关键词:

摘要: Pharmaceutical investigators are searching for preclinical models closely resembling the original cancer and predicting clinical outcome. This study compares drug response of three in vitro 3D-drug screening with different complexity. Tumor cell line spheroids were generated from lines Caco-2, DLD-1, COLO 205, HT-29 HCT-116, treated clinically relevant combination therapies, namely 5-FU/oxaliplatin (FO), 5-FU/irinotecan (FI) molecular drugs Cetuximab, Trastuzumab, Vorinostat Everolimus. Treatment results compared originated tumor (Caco-2, DLD-1) co-cultured stromal cells (PBMCs, cancer-associated fibroblasts colorectal origin) directly prepared colon tissues. Different microenvironment compositions altered spheroid patterns. Adding PBMCs increased resistance to FO treatment by 10-15% Caco-2 DLD-1 but decreased FI 16% spheroids. Fibroblast co-cultures 38% had no impact on FO. tissue revealed distinct pattern subgroups not detectable 3D models. The model mimics both characteristics therefore is an invaluable pharmaceutical development.

参考文章(53)
Lei Huang, A-Man Xu, Sha Liu, Wei Liu, Tuan-Jie Li, Cancer-associated fibroblasts in digestive tumors World Journal of Gastroenterology. ,vol. 20, pp. 17804- 17818 ,(2014) , 10.3748/WJG.V20.I47.17804
Jagdish Mahale, Gintare Smagurauskaite, Karen Brown, Anne Thomas, Lynne M. Howells, The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention? International Journal of Cancer. ,vol. 138, pp. 30- 44 ,(2016) , 10.1002/IJC.29447
Linda K. Woods, Laurie A. Quinn, George E. Moore, Toni U. Semple, Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model Cancer Research. ,vol. 38, pp. 1345- 1355 ,(1978)
Paul Calabresi, Daniel L. Dexter, James A. Barbosa, N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Research. ,vol. 39, pp. 1020- 1025 ,(1979)
D Abigerges, G G Chabot, J P Armand, P Hérait, A Gouyette, D Gandia, Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. Journal of Clinical Oncology. ,vol. 13, pp. 210- 221 ,(1995) , 10.1200/JCO.1995.13.1.210
Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, Helen K Angell, Anne Berger, Christine Lagorce, Alessandro Lugli, Inti Zlobec, Arndt Hartmann, Carlo Bifulco, Iris D Nagtegaal, Richard Palmqvist, Giuseppe V Masucci, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Michele Maio, Luigi Laghi, Fabio Grizzi, Martin Asslaber, Corrado D'Arrigo, Fernando Vidal‐Vanaclocha, Eva Zavadova, Lotfi Chouchane, Pamela S Ohashi, Sara Hafezi‐Bakhtiari, Bradly G Wouters, Michael Roehrl, Linh Nguyen, Yutaka Kawakami, Shoichi Hazama, Kiyotaka Okuno, Shuji Ogino, Peter Gibbs, Paul Waring, Noriyuki Sato, Toshihiko Torigoe, Kyogo Itoh, Prabhu S Patel, Shilin N Shukla, Yili Wang, Scott Kopetz, Frank A Sinicrope, Viorel Scripcariu, Paolo A Ascierto, Francesco M Marincola, Bernard A Fox, Franck Pagès, None, Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. The Journal of Pathology. ,vol. 232, pp. 199- 209 ,(2014) , 10.1002/PATH.4287
Meghna Das Thakur, Nancy K Pryer, Mallika Singh, Mouse tumour models to guide drug development and identify resistance mechanisms The Journal of Pathology. ,vol. 232, pp. 103- 111 ,(2014) , 10.1002/PATH.4285
Cuixia Yang, Linyan He, Pingqing He, Yiwen Liu, Wenjuan Wang, Yiqing He, Yan Du, Feng Gao, Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway Medical Oncology. ,vol. 32, pp. 1- 8 ,(2015) , 10.1007/S12032-014-0352-6
Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore-Bianchi, Dongsheng Tu, Salvatore Siena, Simona Lamba, Sabrina Arena, Milo Frattini, Hubert Piessevaux, Eric Van Cutsem, Chris J. O’Callaghan, Shirin Khambata-Ford, John R. Zalcberg, John Simes, Christos S. Karapetis, Alberto Bardelli, Sabine Tejpar, Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab JAMA. ,vol. 304, pp. 1812- 1820 ,(2010) , 10.1001/JAMA.2010.1535
Ofrat Beyar Katz, Yuval Shaked, Host effects contributing to cancer therapy resistance Drug Resistance Updates. ,vol. 19, pp. 33- 42 ,(2015) , 10.1016/J.DRUP.2014.12.002